ODOURLESS
Does anyone want odourless cannabis?
The lab results are in on Brampton-based CannabCo Pharmaceutical Corp.’s proprietary cannabis strain, The Odourless Cannabis™, which—you guessed it—was designed to not have the distinct flavours and aromas usually associated with quality bud.
According to a press release:
- A 50-page report was produced by a lab called Scentroid at the request of one of the “big four” financial consulting firms
- Multiple tests were conducted to ensure results were reproducible
- The report concluded odour was “barely detectable” within four metres, compared to regular cannabis, where odour is detectable within 50 metres
- The company thinks property managers of rental buildings where cannabis consumption has been banned may be receptive to the use of the odourless product
The response on Twitter, however, was skeptical: “Finally,” tweeted Ryan Lee, sarcastically. “No-Spectrum cannabis! All I hear all day, every day is how consumers just can’t stand the smell or flavour of cannabis; they want to get high without all those nasty terps & volatiles!”
Enjoy Cannabis Daily each morning at 7 a.m.
INTOXICATING
US Hemp Roundtable issues warning on intoxicating products
National advocacy group the US Hemp Roundtable issued a press release expressing concern over a growing number of products sold as hemp that are actually intoxicating or impairing.
Last year, the group warned about Delta-8 THC products that were being sold in regular stores rather than licensed cannabis stores. Now, they’re concerned about delta-9 THC products that are derived from hemp, but are over the concentration allowed by the Farm Bill, which limits hemp-derived products to 0.3% THC.
“This kind of marketing is not simply a threat to public health and safety — particularly for kids that might purchase these products at retail — it undermines the integrity of the legal hemp industry, and ultimately threatens the livelihoods of farmers themselves,” said Russell Coleman, Ethics Counsel to the U.S. Hemp Roundtable.
IMPRESSIVE
Arizona sales reached $1.4 billion last year
Residents of Arizona sure love their cannabis, reports Benzinga, where people spent more than $1.4 billion on regulated products in 2021, setting another new sales record.
The details
- Adult-use sales kicked off in January last year
- It’s already pulled in $650 million in revenues
- By comparison, the 10-year-old medical market brought in $752 million in 2021
- Adult-use tax revenue reached $104.1 million, medical taxes contributed almost $218 million to state coffers
REMOTE
Kanabo snaps up UK telemedicine company the GP Service
European medical cannabis company Kanabo, which acquired Materia last year, has now scooped up UK telemedicine and online primary healthcare service providers The GP Service (GPS) in a deal worth £14 million, reports BusinessCann.
The company offers speedy appointments with UK general practitioners (£39.99) and rapid prescription services (£7.49).
The takeaway
“Kanabo’s acquisition of The GP Service will facilitate the rapid growth of the existing GP digital and telemedicine business and will establish a new and fully compliant channel to market for Kanabo’s products for medical patients,” writes BusinessCann. “Through improved access to these products, Kanabo hopes to make a substantial contribution to improving outcomes for thousands of patients in the UK and Europe.”
